What is cytotoxic chemotherapy and when is it used for MDS?
MDS experts, Dr Alan List and Dr David Sallman, provide an overview of cytotoxic chemotherapy for the treatment of myelodysplastic syndromes (MDS). This treatment uses chemotherapy to kill the abnormal cells in your bone marrow. Higher-risk MDS can potentially progress to acute myeloid leukemia (AML), so some patients with higher-risk MDS may receive the same chemotherapy treatment as AML patients.
Share with family and friends:
Click here to take our Myelodysplastic Syndromes (MDS) SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by
the Myelodysplastic Syndromes Foundation, Inc and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.